Inventor · disambiguated record
Zhenyan Li
Also filed as: LI ZHENYAN
6 granted patents·11 pending applications·29 citations·filing 2017–2021
78Inventor score
Files withSHANGHAI EPIPROBE BIOTECHNOLOGY CO LTD11SICHUAN TYRE & RUBBER CO LTD4SHANGHAI PUBLIC HEALTH CLINICAL CT2
Top patents by PatentIndex Score
17 records- 0171USD944720STireSICHUAN TYRE & RUBBER CO LTD·Filed 2020·Granted Mar 1, 2022·6 cites·1 claims
- 0271USD843314STireSICHUAN TYRE & RUBBER CO LTD·Filed 2017·Granted Mar 19, 2019·16 cites·1 claims
- 0369USD944719STireSICHUAN TYRE & RUBBER CO LTD·Filed 2020·Granted Mar 1, 2022·5 cites·1 claims
- 0450US12251434B2Target sequence of RNA virus and use thereofSHANGHAI PUBLIC HEALTH CLINICAL CT·Filed 2021·Granted Mar 18, 2025·0 cites·7 claims
- 0550US2024294976A1Kit and method for detecting nucleic acid and uses thereofSHANGHAI EPIPROBE BIOTECHNOLOGY CO LTD·Filed 2021·Application pending·0 cites
- 0649US12281361B2Methylation modification-based tumor marker STAMP-EP2SHANGHAI EPIPROBE BIOTECHNOLOGY CO LTD·Filed 2019·Granted Apr 22, 2025·0 cites·6 claims
- 0749US2025027161A1Tumor marker and application thereofSHANGHAI EPIPROBE BIOTECHNOLOGY CO LTD·Filed 2021·Application pending·0 cites
- 0848US2023135239A1Drug for treating severe acute respiratory syndrome caused by coronavirus and complications thereof and use of the drugSHANGHAI PUBLIC HEALTH CLINICAL CT·Filed 2021·Application pending·0 cites
- 0947US2022333204A1Tumor marker stamp-ep9 based on methylation modification and application thereofSHANGHAI EPIPROBE BIOTECHNOLOGY CO LTD·Filed 2020·Application pending·0 cites
- 1044US2022177973A1Methylation modification-based tumor marker stamp-ep6SHANGHAI EPIPROBE BIOTECHNOLOGY CO LTD·Filed 2019·Application pending·0 cites
- 1144US2022220560A1Tumor marker stamp-ep3 based on methylation modificationSHANGHAI EPIPROBE BIOTECHNOLOGY CO LTD·Filed 2019·Application pending·0 cites
- 1244US2022195528A1Tumor marker stamp-ep5 based on methylated modificationSHANGHAI EPIPROBE BIOTECHNOLOGY CO LTD·Filed 2019·Application pending·0 cites
- 1344US2022177972A1Methylation modification-based tumor marker stamp-ep4SHANGHAI EPIPROBE BIOTECHNOLOGY CO LTD·Filed 2019·Application pending·0 cites
- 1443US2022298577A1Methylation-based modified tumor marker stamp-ep8 and application thereofSHANGHAI EPIPROBE BIOTECHNOLOGY CO LTD·Filed 2020·Application pending·0 cites
- 1543US2022275452A1Tumor marker stamp-ep7 based on methylated modification and use thereofSHANGHAI EPIPROBE BIOTECHNOLOGY CO LTD·Filed 2020·Application pending·0 cites
- 1643US2021395828A1Methylation modification-based tumor marker stamp-ep1SHANGHAI EPIPROBE BIOTECHNOLOGY CO LTD·Filed 2019·Application pending·0 cites
- 1733USD828286STire treadSICHUAN TYRE & RUBBER CO LTD·Filed 2017·Granted Sep 11, 2018·2 cites·1 claims
Join the waitlist — get patent alerts
Get an alert when Zhenyan Li files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →